Expression of CCL27 in Middle Ear Cholesteatoma

Yan Edward; Eva Decroli; Hirowati Ali; Djong Hon Tjong

doi:10.3889/oamjms.2021.6358

Authors

Yan Edward Department of Otorhinolaryngology, Faculty of Medicine, Andalas University, Padang, Indonesia
Eva Decroli Department of Otorhinolaryngology, Faculty of Medicine, Andalas University, Padang, Indonesia
Hirowati Ali Department of Otorhinolaryngology, Faculty of Medicine, Andalas University, Padang, Indonesia
Djong Hon Tjong Department of Otorhinolaryngology, Faculty of Mathematics and Natural Sciences, Andalas University, Padang, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2021.6358

Keywords:

Expression, CCL27, Cholesteatoma

Abstract

BACKGROUND: Cholesteatoma is a lesion of the temporal bone lined by stratified squamous epithelium that contains desquamated keratin. Cholesteatoma is considered more aggressive during childhood. The molecular mechanism of the pathogenesis of cholesteatoma formation is still unclear. Previous studies reported on immunohistochemical examination and quantitative polymerase chain reaction (PCR) found that TCN1 and CCL27 were involved in the process of cholesteatoma keratinocytes and dermal endothelial cells. In skin tumors derived from keratinocytes, there is a protective mechanism of antitumor T cell-mediated by reducing CCL27 expression.

AIM: The objective of this study was to investigate the expression of chemokine ligand 27 (CCL27) in cholesteatoma.

METHODS: This is a cross-sectional comparative study. Cholesteatoma specimens were obtained from 15 patients who underwent surgery and 15 normal retroauricular skin as control. The specimen’s gene expression was examined with real-time PCR (RT-PCR).

RESULTS: The expression of CCL27 was 36.215 ± 45.848 ng/ul in cholesteatoma, while it is 9.692 ± 15.760 ng/ul in normal retroauricular skin. The expression of CCL 27 in cholesteatoma was higher than in normal retroauricular skin, but it was not significant (p > 0.05)

CONCLUSION: The expression of CCL27 in cholesteatoma was higher than in normal retroauricular skin.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

World Health Organization. Chronic Suppurative Otitis Media, Burden of Illness and Management Options, WHO Library. Geneva: World Health Organization; 2004.

Utami TF, Sudarman K, Udji B, Rianto D, Christanto A. Allergic Rhinitis as a Risk Factor of Chronic Suppurative Otitis Media. Cermin Dunia Kedokt. 2010;179:425-9.

Darmawan AB, Anjarwati DU. The Sensitivity Difference of Eardrop Antibiotic against Pseudomonas aeruginosa in chronic suppurative otitis media. Oto Rhino Laryngol. Indones. 2012;42(2):77-82. https://doi.org/10.32637/orli.v42i2.22 DOI: https://doi.org/10.32637/orli.v42i2.22

Helmi H. Otitis media supuratif kronis. In: Otitis Media Supuratif Kronis Pengetahuan Dasar Terapi Medik Mastoidektomi Timpanoplasti. Jakarta: Balai Penerbit FKUI; 2005. https://doi.org/10.32637/orli.v49i20.302 DOI: https://doi.org/10.32637/orli.v49i20.302

Likus W, Siemianowicz K, Markowski J, Wiaderkiewicz J, Kostrząb-Zdebel A, Jura-Szołtys E, et al. Bacterial infections and osteoclastogenesis regulators in men and women with cholesteatoma. Arch Immunol Ther Exp (Warsz). 2016;64(3):241-7. https://doi.org/10.1007/s00005-015-0373-7 PMid:26584851 DOI: https://doi.org/10.1007/s00005-015-0373-7

Maniu A, Harabagiu O, Schrepler MP, Cătană A, Fănuţă B, Mogoantă CA. Molecular biology of cholesteatoma. Rom J Morphol Embryol. 2014;55(1):7-13. PMid:24715159

Mayer TA, Strunk CL, Lampert PR. Cholesteatoma. In: Johnson J, Rosen C, editors. Head and Neck Surgery Otolaryngology. Philadelphia, PA: Lippincot William & Wilkins; 2014.

Kuo CL. Etiopathogenesis of acquired cholesteatoma: Prominent theories and recent advances in biomolecular research. Laryngoscope. 2015;125(1):234-40. https://doi.org/10.1002/lary.24890 PMid:25123251 DOI: https://doi.org/10.1002/lary.24890

Jackler RK, Santa Maria PL, Varsak YK, Nguyen A, Blevins NH. A new theory on the pathogenesis of acquired cholesteatoma: Mucosal traction. Laryngoscope. 2015;125 Suppl 4:S1-14. https://doi.org/10.1002/lary.25261 PMid:26013635 DOI: https://doi.org/10.1002/lary.25261

Kuo CL, Shiao AS, Yung M, Sakagami M, Sudhoff H, Wang CH, et al. Updates and knowledge gaps in cholesteatoma research. Biomed Res Int. 2015;2015:854024. https://doi.org/10.1155/2015/854024 PMid:25866816 DOI: https://doi.org/10.1155/2015/854024

Hamed MA, Nakata S, Sayed RH, Ueda H, Badawy BS, Nishimura Y, et al. Pathogenesis and bone resorption in acquired cholesteatoma: Current knowledge and future prospectives. Clin Exp Otorhinolaryngol. 2016;9(4):298-308. https://doi.org/10.21053/ceo.2015.01662 PMid:27440129 DOI: https://doi.org/10.21053/ceo.2015.01662

Kanemaru SI, Kikkawa Y, Omori K, Ito J. Bone destructive mechanisms of cholesteatoma. Laryngoscope. 2010;120(S3):S79. https://doi.org/10.1002/lary.21268 DOI: https://doi.org/10.1002/lary.21268

Pivarcsi A, Müller A, Hippe A, Rieker J, van Lierop A, Steinhoff M, et al. Tumor immune escape by the loss of homeostatic chemokine expression. Proc Natl Acad Sci USA. 2007;104(48):19055-60. PMid:18025475 DOI: https://doi.org/10.1073/pnas.0705673104

Macias JD, Gerkin RD, Locke D, Macias MP. Differential gene expression in cholesteatoma by DNA chip analysis. Laryngoscope. 2013;123 Suppl S5:S1-21. https://doi.org/10.1002/lary.24176 PMid:23670528 DOI: https://doi.org/10.1002/lary.24176

Liu W, Yin T, Ren J, Li L, Xiao Z, Chen X, et al. Activation of the EGFR/Akt/NF- KB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium. Eur Arch Otorhinolaryngol. 2014;27(2):1265-73. https://doi.org/10.1007/s00405-013-2403-6 PMid:23463347 DOI: https://doi.org/10.1007/s00405-013-2403-6

Menglu Z, Yongtuan LI. Expression of chemokine ligand 27 in secondary middle ear. J Shandong Univ. 2017;31(6):46-8.

Karakawa M, Komine M, Hanakawa Y, Tsuda H, Sayama K, Tamaki K, et al. CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes. J Cell Physiol. 2014;229(12):1935-45. https://doi.org/10.1002/jcp.24643 PMid:24710735 DOI: https://doi.org/10.1002/jcp.24643

Gazel A, Nijhawan RI, Walsh R, Blumenberg M. Transcriptional profiling defines the roles of ERK and p38 kinases in epidermal keratinocytes. J Cell Physiol. 2008;215(2):292-308. https://doi.org/10.1002/jcp.21394 PMid:18247374 DOI: https://doi.org/10.1002/jcp.21394

Edward Y, Munilson J, Rosalinda R, Ali H, Irfandy D, Swanda D. Expression of tumor necrosis factor-a and interleukin-6 in chronic suppurative otitis media. Turk J Immunol. 2019;7(1):1-5. https://doi.org/10.25002/tji.2019.782 DOI: https://doi.org/10.25002/tji.2019.782